No external pressure to accelerate Covaxin development: Bharat Biotech

Hyderabad: Vaccine-maker Bharat Biotech has denied that there was any external pressure to accelerate development of Covaxin, its vaccine for Covid-19.

“We condemn the targeted narrative against Covaxin put forth by a select few individuals and groups who have no expertise in vaccines or vaccinology. It is well known that they helped perpetuate misinformation and fake news throughout the pandemic. They are unable to comprehend global product development and licensure processes,” the Hyderabad-based company said in a statement on Thursday.

“The pressure was all internal to develop a safe, and effective vaccine for the Covid-19 pandemic, to save lives and livelihoods in India and globally,” it added.

The company claimed that Covaxin is one of the most highly studied covid-19 vaccines worldwide.

Covaxin was evaluated in about 20 preclinical studies, including three challenge trials and nine human clinical studies, more than any other Indian Covid-19 vaccine. These trials have clearly demonstrated safety and efficacy of Covaxin, Bharat Biotech said.

The vaccine-maker further claimed that with several hundred million doses administered worldwide, Covaxin has demonstrated an excellent safety record with minimal adverse events and no vaccine associated cases detected for myocarditis or thrombocytopenia.

“The entire product development and clinical studies were executed as per global guidelines and submitted worldwide. Data from Covaxin has resulted in more than 20 publications, documenting every aspect of its development.”

It termed as “incorrect and erroneous’ the recent media reports around the approvals for Covaxin.

“These few individuals and organizations were mostly involved in fake news and false information during the pandemic. They fail to understand product development and licensure pathways worldwide,” reads the statement.

It pointed out that the phase 1 study for Covaxin was one of the largest in the world, resulting in both the 3 and 6 mcg doses demonstrating safety and comparable immunogenicity.

The decision to proceed to phase III trials was taken based on data from phase I studies and results from successful animal challenge trials.

The phase II studies were designed to determine if the lower dose of 3 mcg would be effective, instead of the 6 mcg dose, which would have doubled our manufacturing capacity. In the interest of public health, it was decided to proceed with the 6 mcg dose for phase III clinical trials.

According to Bharat Biotech, vaccines against ebola and monkey pox, were approved by stringent regulatory agencies in developed countries based on phase I and II clinical data only and without phase III data.

“If such an approval was given by regulators in India, there would be an uproar, but the same people and organisations remain silent, demonstrating their hypocrisy.

“While these people and organizations were busy with false information and fake news during the pandemic, more than 1,000 personnel at Bharat Biotech across India were busy developing, testing, manufacturing and distributing Covaxin.

“Our diligent efforts have resulted in an universal Covid-19 vaccine for adults and children alike, which can be administered repeatedly as booster doses without safety concerns. The Bharat Biotech team is extremely proud of its efforts to develop a novel Covid-19 vaccine for India and the world. These efforts to discredit our work will not deter us,” it added.IANS

India records progress in maternal deaths, lowest in Kerala, highest in MP & UP; 8 states meet SDGs

The country’s MMR declined to 97 during the period 2018-2020 from 113 during 2016- 18 and 130 during 2014-16 Assam recorded an MMR of 195 in 2018-20. Madhya Pradesh was...

WHO renames monkeypox as ‘mpox’ to avoid stigma

Geneva: To avoid racist stereotypes and stigmatisation, the WHO has recommended that the monkeypox virus be renamed "mpox". Both names -- mpox and monkeypox -- will be used simultaneously for...

‘Male infertility highest in Bengal’

Male infertility was on the rise across India, and Kolkata was no exception: Experts ‘A steep 10. 8% of our male patients in Bengal had zero sperm count in 2021’...

Eye camps banned in Kanpur after 8 lose eyesight

  Kanpur:  The Chief Medical Officer (CMO) of Kanpur has banned public and private hospitals from holding any eye check-up camps until further orders. The decision comes days after eight...

Can universal vaccine counter future pandemic?

The research opens up a world of new possibilities with mRNA vaccine technology 'Strong antibody immune responses were shown against all 20 different flu strains' 'There will be far less...

Water experts dismiss Govt claim of increase in groundwater recharge

New Delhi: Water experts and activists have rejected the findings of the latest  government report on ground water assessment which claims that there has been an increase in water recharge...

Why measles outbreak intensifies in India?

There is now an imminent threat of measles spreading in various regions globally, as Covid-19 led to a steady decline in vaccination coverage and weakened surveillance of the disease, the...

Vaccinated people now make majority of Covid deaths in US: Report

New York:  In a startling revelation, a Washington Post analysis has found that more vaccinated people are now dying of the Covid disease and 58 per cent of coronavirus deaths...

2 billion people in world drink water contaminated with faeces

Naz Asghar New Delhi: There are at least 2 billion people in the world who drink water drawn from a source contaminated with faeces, and 3.6 billion people live without...

Centre deploys high-level teams to assess increasing measles cases among kids in states

New Delhi: The Union Health Ministry on Wednesday said that it has decided to depute three high-level multi-disciplinary 3-member teams to Ranchi, Ahmedabad, and Malappuram (Kerala) to take stock of the...

Beijing faces ‘most severe Covid test yet’

Beijing:  Authorities in Beijing have said that the Chinese capital is facing the "most severe Covid test yet" after three new deaths were reported in six months, plunging parts of...

Covid can deteriorate diabetes, associated heath disease: Indian-origin scientist

  New York: Covid-19 can alter a person's genetic makeup which can enhance the proliferation of disease and cause further deterioration in diabetes and associated heart disease, an Indian-origin researcher...

Read Previous

Mining scam: Jharkhand CM appears before ED, alleges conspiracy to destabilise govt

Read Next

Making oceans critical to climate action: TERI

Leave a Reply

Your email address will not be published.

WP2Social Auto Publish Powered By : XYZScripts.com